Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

#CTAD26: Biogen’s tau drug slows Alzheimer’s more after nearly two years

BOSTON — The benefits of Biogen's experimental Alzheimer's drug seem to get better with time. Over the summer, Biogen reported that the lowest dose of its gene-silencing therapy diranersen slowed the disease by ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at endpoints.news →

More in Health & Medicine

More from Wednesday 18 November →